The use of antiinflammatory therapy and macrolides in bronchiectasis.

Airway inflammation is a major component of disease pathogenesis in bronchiectasis, suggesting that antiinflammatory therapies could be of benefit in treatment. This article addresses the use of anti-inflammatory/immunomodulatory therapies in the management of patients with bronchiectasis and individually discusses the use of corticosteroids, macrolides, and other potential anti-inflammatory agents.